Michael Mussallem - Edwards Lifesciences Insider

EW -- USA Stock  

USD 151.26  5.31  3.64%

Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Edwards Lifesciences Corporationration He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company in particular, built over a more than 35year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcarerelated organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships, which are helpful in developing our Boards strategic perspective, and enhanced his leadership of the Company and contributions to our Board.
Age: 64  Chairman Since 2000      
949-250-2500  http://www.edwards.com

Michael Mussallem Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 11.47 % which means that for every $100 of asset it generated profit of $11.47. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 21.51 % which means that it produced $21.51 on every 100 dollars invested by current stockholders.
The company reports 1.19 B of total liabilities with total debt to equity ratio (D/E) of 37.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 2.23 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Found 7 records


Jeffrey EberweinDigirad Corporation
George WinnElectromed
Philippe ChauveauEDAP TMS S A
Alfred MannSecond Sight Medical Products
Patrick PaceEncision
Kelvyn CullimoreDynatronics Corporation
Stephen CraneyElectromed

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Independent Director
Wesley Schack, Presiding Independent Director
Larry Wood, Corporate VP of Transcatheter Heart Valve
Nicholas Valeriani, Director
Leslie Heisz, Director
Catherine Szyman, Corporate Vice President Critical Care
Martha Marsh, Director
Huimin Wang, Corporate Vice President Japan, Asia Pacific
JeanLuc Lemercier, Corporate Vice President EMEA (Europe, Middle East and Africa)
Barbara McNeil, Independent Director
Steven Loranger, Director
William Link, Independent Director
Scott Ullem, CFO and Corporate VP
Patrick Verguet, Corporate VP of EMEA, Canada and Latin America
Kieran Gallahue, Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
David Erickson, Vice President - Investor Relations
Donald Bobo, Corporate VP of Strategy and Corporate Devel.
Michael Mussallem, Chairman and CEO

Stock Performance Indicators

Did you try this?

Run Equity Search Now


Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Equity Search

Edwards Lifesciences Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Edwards Lifesciences and Digirad. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com